STRUCTURE AND FUNCTION OF CARBOXYPEPTIDASE M
羧肽酶 M 的结构和功能
基本信息
- 批准号:2141764
- 负责人:
- 金额:$ 20.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1989
- 资助国家:美国
- 起止时间:1989-05-01 至 1999-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This proposal is a continuation of studies on carboxypeptidase M (CPM),
which is membrane-bound in many tissues and cells and may regulate peptide
hormone activity at the cell surface. The long term objective is to
understand the in vivo functions of CPM. Three areas of investigation will
be emphasized.
A) THE STRUCTURE OF CPM. Wild type and mutant CPM (generated by 3 prime
truncation or site-directed mutagenesis), expressed in a baculovirus
system, will be characterized to determine: 1. Whether G1n249 is the side-
chain binding residue that mediates its specificity for Arg or Lys; 2. If
the C-terminal hydrophobic region of CPM is a signal for
phosphatidylinositol-glycan (PI-G) anchoring. Biochemical studies on
purified enzyme will determine if Ser 406 is the PI-G attachment site and
whether an alternate transmembrane form of CPM is present in kidney.
Elucidation of the structure of the CPM gene will help identify possible
regulatory regions.
B) THE LOCALIZATION OF CPM. It is hypothesized that renal CPM is present
in both the proximal tubules and the distal nephron and, subcellularly it
is enriched in caveolae of the plasma membrane. The localization of CPM in
kidney will be studied by both immunofluorescent light microscopy and
immunogold staining with electron microscopy. The distribution of renal
CPM mRNA will be determined by in situ hybridization. Using biochemical
techniques, CPM enrichment in caveolae from MDCK cells will be studied.
C) THE REGULATION OF CPM. Hypothesis: release of CPM and other
phosphatidylinositol-glycan (PI-G) anchored proteins from the cell by a
phospholipase generates a diglyceride signal that upregulates enzyme
synthesis via a protein kinase C. This signalling pathway depends on the
functional integrity of plasma membrane caveolae and may be specific to
apical or basolateral domains in polarized epithelial cells. MDCK cells
will be used to determine: I. whether other PI-G anchored protein are
upregulated by stimuli that upregulate CPM; 2. whether the stimulus
and/or the response is specific to the apical or basolateral domain in
MDCK cells. 3. whether the integrity of caveolae is required for the
upregulation of CPM.
These studies should provide insight into potential functions of CPM in
physiological and pathophysiological processes. For example, in the
kidney CPM may control the activity of bradykinin to regulate salt and
water excretion. In inflammatory conditions, it could generate an agonist
(des-Arg9-bradykinin) for the BI receptor which is upregulated by
endotoxin and interleukin I. By cleaving C-terminal Arg from proteins or
peptides, it may provide the precursor of nitric oxide. The regulation of
CPM and other PI-G anchored proteins may be relevant to pathological
conditions that result in their increased release into extracellular
fluids (e.g., psoriasis).
本课题是对羧基肽酶M (CPM)研究的延续。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Randal A Skidgel其他文献
Randal A Skidgel的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Randal A Skidgel', 18)}}的其他基金
Developing a new drug for treating myocardial ischemia/reperfusion injury
开发治疗心肌缺血/再灌注损伤的新药
- 批准号:
10491205 - 财政年份:2021
- 资助金额:
$ 20.38万 - 项目类别:
Developing a new drug for treating myocardial ischemia/reperfusion injury
开发治疗心肌缺血/再灌注损伤的新药
- 批准号:
10325868 - 财政年份:2021
- 资助金额:
$ 20.38万 - 项目类别:
Targeting integrin outside-in signaling for treating sepsis
靶向整合素由外向内信号传导治疗脓毒症
- 批准号:
10461718 - 财政年份:2018
- 资助金额:
$ 20.38万 - 项目类别:
Targeting integrin outside-in signaling for treating sepsis
靶向整合素由外向内信号传导治疗脓毒症
- 批准号:
10625353 - 财政年份:2018
- 资助金额:
$ 20.38万 - 项目类别:
Post-translational Regulation of High Output NO and Endothelial Barrier Dysfuncti
高输出 NO 和内皮屏障功能障碍的翻译后调节
- 批准号:
8059128 - 财政年份:2011
- 资助金额:
$ 20.38万 - 项目类别:
Post-Translational Regulation of High Output NO and Endothelial Barrier Dysfuncti
高输出 NO 和内皮屏障功能障碍的翻译后调节
- 批准号:
7367821 - 财政年份:2007
- 资助金额:
$ 20.38万 - 项目类别:
Post-Translational Regulation of High Output NO and Endothelial Barrier Dysfuncti
高输出 NO 和内皮屏障功能障碍的翻译后调节
- 批准号:
7312500 - 财政年份:2006
- 资助金额:
$ 20.38万 - 项目类别:
相似国自然基金
原生动物四膜虫生殖小核(germline nucleus)体功能(somatic function)的分子基础研究
- 批准号:31872221
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
相似海外基金
Structure and Function of Novel Carboxypeptidase gp180
新型羧肽酶gp180的结构与功能
- 批准号:
07680679 - 财政年份:1995
- 资助金额:
$ 20.38万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Function and Structure of Carboxypeptidase gp180.
羧肽酶 gp180 的功能和结构。
- 批准号:
05808056 - 财政年份:1993
- 资助金额:
$ 20.38万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)